A Phase 2 clinical trial of GDC-0310 for the treatment of pain
Phase of Trial: Phase II
Latest Information Update: 03 Aug 2017
At a glance
- Drugs GDC 0310 (Primary)
- Indications Pain
- Focus Therapeutic Use
- 03 Aug 2017 According to a Xenon Pharmaceuticals media release, the company plans to initiate this study in the first quarter of 2018.
- 11 Mar 2017 New trial record
- 08 Mar 2017 The company anticipates initiating this trial in 2017, according to a Xenon Pharmaceuticals media release.